Literature DB >> 3337917

Fatal legionellosis in patients with malignant hematologic diseases.

D Schürmann1, B Ruf, F Pfannkuch, I Horbach, H D Pohle.   

Abstract

Pneumonia was present in 70/157 (44.6%) autopsied patients with malignant hematologic diseases. In 16/70 patients (22.9%), legionellae were found to be the causative agents by screening lung tissue specimens with the direct fluorescent antibody method. In 5/16 patients with Legionella pneumonia, in whom legionellosis had been suspected clinically, the diagnosis had already been established by serology, urinary Legionella antigen detection, and culture. These results provide evidence that legionellosis is an important pneumonia etiology in patients with malignant hematological diseases. Thus, Legionella diagnostics should be applied routinely, and antibiotics effective in the treatment of legionellosis should be added to the usual therapy in patients with etiologically unexplained pneumonias. In view of the common occurrence of relapses of Legionella pneumonia, antibiotic therapy should be continued for an extended period.

Entities:  

Mesh:

Year:  1988        PMID: 3337917     DOI: 10.1007/bf00321056

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  18 in total

1.  Rapid detection of Legionella antigen in tissues and body fluids.

Authors:  F J Fehrenbach; I Horbach; B Ruf; D Shurmann; H D Pohle
Journal:  Isr J Med Sci       Date:  1986-10

Review 2.  Infectious complications in leukemic patients.

Authors:  G P Bodey; R Bolivar; V Fainstein
Journal:  Semin Hematol       Date:  1982-07       Impact factor: 3.851

3.  Demonstration of the agent of Legionnaires' disease in tissue.

Authors:  F W Chandler; M D Hicklin; J A Blackmon
Journal:  N Engl J Med       Date:  1977-12-01       Impact factor: 91.245

4.  Causes of initial remission induction failure in acute myelogenous leukemia.

Authors:  E H Estey; M J Keating; K B McCredie; G P Bodey; E J Freireich
Journal:  Blood       Date:  1982-08       Impact factor: 22.113

5.  Brief communication: Legionnaire's disease successfully treated in acute myelocytic leukemia during severe neutropenia.

Authors:  T H Guthrie; P Mahizhnan
Journal:  Med Pediatr Oncol       Date:  1983

6.  Comparison of cross-staining reactions by Pseudomonas spp. and fluorescein-labeled polyclonal and monoclonal antibodies directed against Legionella pneumophila.

Authors:  F C Tenover; P H Edelstein; L C Goldstein; J C Sturge; J J Plorde
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

Review 7.  Legionella infections: a review of five years of research.

Authors:  R D Meyer
Journal:  Rev Infect Dis       Date:  1983 Mar-Apr

8.  Legionnaires' disease: new clinical perspective from a prospective pneumonia study.

Authors:  V L Yu; F J Kroboth; J Shonnard; A Brown; S McDearman; M Magnussen
Journal:  Am J Med       Date:  1982-09       Impact factor: 4.965

9.  [Pneumonia in acute leukemias].

Authors:  H H Hennemann; W Wundt; R Schuh; B Bauer
Journal:  Klin Wochenschr       Date:  1986-06-02

10.  Legionnaires' disease and hairy-cell leukemia. An unfortuitous association?

Authors:  C Cordonnier; J P Farcet; L Desforges; C Brun-Buisson; J P Vernant; M Kuentz; E Dournon
Journal:  Arch Intern Med       Date:  1984-12
View more
  1 in total

1.  Detection of Legionella Pneumophila in Urine and Serum Specimens of Neutropenic Febrile Patients with Haematological Malignancies.

Authors:  Nastaran Farzi; Zahra Abrehdari-Tafreshi; Omid Zarei; Leili Chamani-Tabriz
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.